IQVIA Holdings Inc. to Present at Barclays 28th Annual Global Healthcare Conference

On March 2, 2026, IQVIA Holdings Inc. (NYSE:IQV) announced that Mike Fedock, the company’s Executive Vice President and Chief Financial Officer, will be speaking at the highly anticipated Barclays 28th Annual Global Healthcare Conference. The presentation is scheduled for Thursday, March 12, 2026, at 9:30 a.m. ET.

For those interested in following the discussion, a live audio webcast of the presentation will be accessible through the IQVIA Investor Relations website. After the event, a replay of the webcast will be available for later viewing, allowing stakeholders and interested parties to catch up on the insights shared during the conference.

IQVIA is recognized as a leading global provider of clinical research services, commercial insights, and healthcare intelligence tailored for the life sciences and healthcare sectors. The company is committed to delivering actionable insights and services powered by its proprietary IQVIA Connected Intelligence™. This innovative approach integrates high-quality health data with advanced analytics and healthcare-grade artificial intelligence (AI), ensuring that the solutions offered meet the demanding standards of trust, scalability, and precision required by the industry.

With a robust workforce of approximately 93,000 employees across more than 100 countries, IQVIA boasts a wealth of expertise in healthcare, life sciences, data science, technology, and operational excellence. The company is dedicated to accelerating the development and commercialization of groundbreaking medical treatments aimed at improving patient outcomes and enhancing population health on a global scale.

IQVIA takes pride in its position as a global leader in safeguarding individual patient privacy. The company employs a comprehensive array of privacy-enhancing technologies and safeguards to ensure the protection of personal information while simultaneously generating and analyzing vast amounts of data. This capability enables healthcare stakeholders to identify disease patterns and correlate them with optimal treatment paths, ultimately leading to better health outcomes.

Furthermore, IQVIA’s insights and execution capabilities are instrumental for biotech firms, medical device manufacturers, pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders. By leveraging deep insights into disease patterns, human behaviors, and scientific advancements, IQVIA aids in advancing the quest for cures.

As the healthcare landscape continues to evolve, IQVIA remains committed to utilizing AI responsibly, ensuring compliance with regulatory standards while prioritizing patient safety.

As a prominent player in the healthcare and life sciences sectors, IQVIA’s participation in the Barclays 28th Annual Global Healthcare Conference represents a significant opportunity for the company to share its vision, innovations, and commitment to improving healthcare outcomes. Stakeholders are encouraged to tune in to the live webcast and engage with the insights that will shape the future of healthcare intelligence and research services.